Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks The latest update is out from Century ...
Bristol-Myers Squibb said it will terminate its collaborative agreement with Merck for Pargluva (muraglitazar), the investigational drug to treat type 2 diabetes. BMS had announced in October that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results